ICON plc (ICLR) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Cerebras Systems falls as TD Cowen cuts price target
- Nasdaq climbs as chip and AI-linked stocks bounce back
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
- Moderna shares rise ahead of cancer vaccine trial results
Jefferies Cuts ICON plc (ICLR) PT, Estimates But Not Rating
April 27, 2016 9:32 AM EDTJefferies analyst, David Windley, cut revenue and EPS projections for ICON plc (NASDAQ: ICLR) '16 and '17 due to slowing backlog conversion and weak bookings . Increased clinical development complexity is a consistent theme for ICLR and the group, lowering revenue visibility. However, repeated margin outperformance expectation for a PFE renewal justify patience and he maintains the Buy rating. PT drops to $80 from $85.
1) Slower Burn Makes... More



